Usfda Approves Lung Cancer Drug
Glenmark Pharma gets USFDA approval for generic lung cancer drug
Glenmark Pharmaceuticals said it has received approval from the US health regulator to market Nintedanib capsules, used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer
 "Glenmark Pharma gets USFDA approval for generic lung cancer drug")
Updated On : 25 Jun 2021 | 12:36 PM IST
USFDA approves AstraZeneca's combo treatment for lung cancer patients
The combo treatment has been approved in the United States for adult patients with extensive-stage small cell lung cancer, the company said
 "USFDA approves AstraZeneca's combo treatment for lung cancer patients")
Updated On : 30 Mar 2020 | 3:13 PM IST
AstraZeneca's immunotherapy drug gets US FDA nod for lung cancer treatment
US FDA granted approval for expanded use of Imfinzi to treat non-small cell lung cancer patients
 "AstraZeneca's immunotherapy drug gets US FDA nod for lung cancer treatment")
Updated On : 17 Feb 2018 | 11:20 PM IST
